首页> 外文期刊>Oncology Research >Knockdown of MED19 by lentivirus-mediated shRNA in human osteosarcoma cells inhibits cell proliferation by inducing cell cycle arrest in the G0/G1 phase.
【24h】

Knockdown of MED19 by lentivirus-mediated shRNA in human osteosarcoma cells inhibits cell proliferation by inducing cell cycle arrest in the G0/G1 phase.

机译:慢病毒介导的shRNA在人骨肉瘤细胞中敲低MED19可以通过诱导G0 / G1期细胞周期停滞来抑制细胞增殖。

获取原文
获取原文并翻译 | 示例
           

摘要

MED 19 is a subunit of the mediator complex, which is a coactivator of RNA polymerase II and also interacts with the downstream coding region of many genes. However, the role of MED19 in osteosarcoma is unknown. In the present study, we applied lentivirus-mediated short hairpin RNA (shRNA)-triggered RNA interference to downregulate MED19 expression in human osteosarcoma SaOS-2 and U2OS cells. Knockdown of MED19 expression was confirmed by real-time PCR and Western blot. It was found that silencing of MED19 resulted in decreased cell viability, colony formation capacity, and DNA synthesis ability in both cells, as well as the G0/G1 phase cell cycle arrest. These results implied that MED19 played an important role in cell growth and cell cycle progression of human osteosarcoma cells. MED19 may be an attractive candidate for the therapeutic target in osteosarcoma.
机译:MED 19是介体复合物的亚基,它是RNA聚合酶II的共激活因子,还与许多基因的下游编码区相互作用。但是,MED19在骨肉瘤中的作用尚不清楚。在本研究中,我们应用慢病毒介导的短发夹RNA(shRNA)触发的RNA干扰来下调人骨肉瘤SaOS-2和U2OS细胞中的MED19表达。通过实时PCR和Western印迹证实了敲低MED19表达。发现MED19沉默导致两个细胞的细胞活力,集落形成能力和DNA合成能力降低,以及G0 / G1期细胞周期停滞。这些结果暗示MED19在人骨肉瘤细胞的细胞生长和细胞周期进程中起重要作用。 MED19可能是骨肉瘤中治疗靶标的诱人候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号